Emerging technology and platforms for cardiotoxicity testing is a research paper published in Toxicology and Applied Pharmacology (2020). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIEHS NIH HHS
Grant: P30 ES030283
NHLBI NIH HHS
Grant: U54 HL120163
NHLBI NIH HHS
Grant: R01 HL122676
NIGMS NIH HHS
Grant: P30 GM127607
NHLBI NIH HHS
Grant: R01 HL147921
NHLBI NIH HHS
Grant: P50 HL120163
NIEHS NIH HHS
Grant: P42 ES023716
National Institutes of Health
Grant: 5R01HL122676-03
Cardiovascular Toxicity of Tobacco Products and Constituents
National Institutes of Health
Grant: 5R01HL147921-02
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure
National Institutes of Health
Grant: 5P30GM127607-03
Center for Excellence in Diabetes and Obesity Research
National Institutes of Health
Grant: 3P42ES023716-03S1
Environmental Exposure and Cardiometabolic Disease
National Institutes of Health
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals